Hydroxyapatite compound


Concise Prescribing Info
Indications/Uses
Prevention of postmenopausal osteoporosis.
Dosage/Direction for Use
Adult : PO As ossein-hydroxyapatite compd: 1,660 mg twice daily.
Dosage Details
Oral
Prophylaxis of postmenopausal osteoporosis
Adult: As ossein-hydroxyapatite compound: 1660 mg bid.
Contraindications
Hypersensitivity. Children <6 yr. Prolonged immobilization accompanied by hypercalciuria.
Special Precautions
Monitor serum calcium level during treatment. To be taken with vitamin D for maximal benefit. Caution when used in renally impaired patients.
Adverse Reactions
Risk of hypercalciuria.
Drug Interactions
Biphosphonates may increase the osteoconductive and regenerative properties of hydroxyapatite when used together.
Action
Description: Hydroxyapatite is a natural mineral with composition similar to that of the mineral in bone. It is prepared from bovine bone and contains calcium, phosphate, trace elements, fluoride and other ions, proteins and glycosaminoglycans.
Disclaimer: This information is independently developed by MIMS based on Hydroxyapatite compound from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in